Skip to main content
Clinical Trials/IRCT20220406054440N1
IRCT20220406054440N1
Recruiting
Phase 1

Comparison of the effectiveness of mirtazapine and citalopram on general health and quality of life in patients with major depression and breast cancer in the oncology ward

Gorgan University of Medical Sciences0 sites42 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Major Depression, Breast Cancer, Mirtazapine, Citalopram.
Sponsor
Gorgan University of Medical Sciences
Enrollment
42
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Gorgan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Females with breast cancer after radiotherapy surgery and undergoing chemotherapy or radiotherapy in stages 1 to 4 of disease progression
  • Age over 18 years and under 65 years
  • Middle school education level and higher
  • Existence of major depression criteria based on DSM\-V criteria

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials